Clinical Trials in Baltimore

Showing 12821-12840 of 20,142 trials

Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access

NCT03300024

The investigators propose a randomized study to compare bovine carotid artery (BCA) biologic grafts and expanded polytetrafluoroethylene grafts (ePTFE) for permanent hemodialysis access.

End Stage Renal DiseaseHemolysisArteriovenous Graft

Johns Hopkins University10 participantsStarted Feb 2015

Baltimore, Maryland, United States

TERMINATED< 1 mile

The Chimerix CMX001 Registry

NCT02167685

The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.

OutcomesSurvival Rates

Jazz Pharmaceuticals550 participantsStarted Jan 2014

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +48 more locations

Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access

The Chimerix CMX001 Registry

Find Trials by Condition in Baltimore

ST266 Versus Standard Care In Treating Partial Thickness Burns

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Recovery, Fatigability, and Proteomic Response to Aerobic Exercise Training in Healthy Individuals

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

The PROOF Study: The PICC Related Obstruction Of Flow Study

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients